monoamine oxidase inhibitors

Preferred Label : monoamine oxidase inhibitors;

MeSH definition : A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414);

MeSH synonym : mao inhibitors; inhibitors, monoamine oxidase; inhibitor, monoamine oxidase; inhibitors, mao; monoamine oxidase inhibitor; MAO Inhibitor; Inhibitor, MAO;

MeSH hyponym : reversible inhibitors of monoamine oxidase; RIMA (Reversible inhibitor of monoamine oxidase A); Reversible Inhibitor of Monoamine Oxidase;

MeSH annotation : DF: MAO INHIB;

Wikipedia link : https://en.wikipedia.org/wiki/Monoamine oxidase inhibitor;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D008996;

UMLS CUI

C0026457;

ATC code(s)
- iproniazide [ATC Code]
- isocarboxazid [ATC Code]
- moclobemide [ATC Code]
- monoamine oxidase b inhibitors [ATC Code]
- nialamide [ATC Code]
- phenelzine [ATC Code]
- toloxatone [ATC Code]
- tranylcypromine [ATC Code]
ATC code(s)
- MAO inhibitors and diuretics [ATC Code]
- monoamine oxidase b inhibitors [ATC Code]
- monoamine oxidase inhibitors, non-selective [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Immunoradiometric Assay [NCIt concept]
- Intraretinal microvascular anomaly due to diabetes mellitus (disorder) [SNOMED CT concept]
- MAO inhibitors [ICHI extension code]
- Monoamine oxidase A inhibitor (disposition) [SNOMED CT concept]
- Monoamine oxidase A inhibitors [ICD-11 Extension code]
- Monoamine oxidase inhibitor [ICHI extension code]
- Monoamine oxidase inhibitor (disposition) [SNOMED CT concept]
- Radioreceptor assay (procedure) [SNOMED CT concept]
- Substance with monoamine oxidase A inhibitor mechanism of action (substance) [SNOMED CT concept]
- immunoradiometric assay [IUPAC Term]
- radioreceptor assay, nos [SNOMED Notion]
CISMeF manual mappings
- Poisoning caused by monoamine oxidase inhibitor (disorder) [SNOMED CT concept]
Currated CISMeF NLP mapping
- MAO inhibitors [ICD-11 Extension code]
- Monoamine Oxidase Inhibitor [NCIt concept]
- Monoamine oxidase inhibitor [ICD-11 Extension code]
- Product containing monoamine oxidase inhibitor (product) [SNOMED CT concept]
- Substance with monoamine oxidase inhibitor mechanism of action (substance) [SNOMED CT concept]
- mao inhibitors [ATC Code]
- monoamine oxidase inhibitor, nos [SNOMED Notion]
Indexing information
- (2E,4E)-1-(2-hydroxyphenyl)-5-phenylpenta-2,4-dien-1-one [MeSH Supplementary Concept]
- (2E,4E)-5-(4-chlorophenyl)-1-(2,4-dihydroxyphenyl)penta-2,4-dien-1-one [MeSH Supplementary Concept]
- (2E,4E)-5-(4-chlorophenyl)-1-(2-hydroxy-4-methoxyphenyl)penta-2,4-dien-1-one [MeSH Supplementary Concept]
- 1-((4-chlorophenyl)(phenyl)methylene)-4-(6-nitrobenzothiazol-2-yl)semicarbazide [MeSH Supplementary Concept]
- 2-(3,4-dimethoxy-phenyl)-4,5-dihydro-1H-imidazole [MeSH Supplementary Concept]
- 6-bromo-8-methoxy-3-(4'-methoxyphenyl)coumarin [MeSH Supplementary Concept]
- 6-methoxy-3-(4-methylphenyl)coumarin [MeSH Supplementary Concept]
- N-((5-(3-(1-benzylpiperidin-4-yl)propoxy)-1-methyl-1H-indol-2-yl)methyl)-N-methylprop-2-yn-1-amine [MeSH Supplementary Concept]
- N-(1-fluoro-3-phenylpropan-2-yl)-N-methylprop-2-yn-1-amine [MeSH Supplementary Concept]
- N-(4-oxo-4H-3,1-benzothiazin-2-yl)-4-phenylbutanamide [MeSH Supplementary Concept]
- chaetoquadrin A [MeSH Supplementary Concept]
- chaetoquadrin B [MeSH Supplementary Concept]
- chaetoquadrin C [MeSH Supplementary Concept]
- minaprine [MeSH Supplementary Concept]
Manual BTNT mappings - CISMeF
- Monoamine oxidase-inhibitor, non-selective [Bloc CIM-11]
MeSH Descriptor(s) used for indexing
- monoamine oxidase [MeSH Descriptor]
Record concept(s)
- RIMA (Reversible inhibitor of monoamine oxidase A) [MeSH concept]
- monoamine oxidase inhibitors [MeSH concept]
- reversible inhibitors of monoamine oxidase [MeSH concept]
See also
- antidepressive agents [MeSH Descriptor]
- serotonin syndrome [MeSH Descriptor]
- sympathomimetics [MeSH Descriptor]
See also (suggested by CISMeF)
- monoamine oxidase [MeSH Descriptor]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 2-(3,4-dimethoxyphenyl)-3-fluoroallylamine [MeSH Supplementary Concept]
- 2-fluoro-2-phenylcyclopropylamine [MeSH Supplementary Concept]
- 3-hydroxy-2-oxoindole [MeSH Supplementary Concept]
- 3-methoxymethyl-7-(4,4,4-trifluorobutoxy)-3,3a,4,5-tetrahydro-1,3-oxazolo(3,4-a)quinolin-1-one [MeSH Supplementary Concept]
- 5-((4-prop-2-ynylpiperazin-1-yl)methyl)quinolin-8-ol [MeSH Supplementary Concept]
- 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline [MeSH Supplementary Concept]
- M32 compound [MeSH Supplementary Concept]
- RS 8359 [MeSH Supplementary Concept]
- amezinium [MeSH Supplementary Concept]
- amiflamine [MeSH Supplementary Concept]
- brofaromine [MeSH Supplementary Concept]
- chlorphenamidine [MeSH Descriptor]
- cimoxatone [MeSH Supplementary Concept]
- clorgyline [MeSH Descriptor]
- cuprizone [MeSH Descriptor]
- desmethylselegiline [MeSH Supplementary Concept]
- furazolidone [MeSH Descriptor]
- harmaline [MeSH Descriptor]
- harmine [MeSH Descriptor]
- iproniazid [MeSH Descriptor]
- isocarboxazid [MeSH Descriptor]
- lazabemide [MeSH Supplementary Concept]
- milacemide [MeSH Supplementary Concept]
- moclobemide [MeSH Descriptor]
- mofegiline [MeSH Supplementary Concept]
- monocrotophos [MeSH Descriptor]
- nialamide [MeSH Descriptor]
- pargyline [MeSH Descriptor]
- phenelzine [MeSH Descriptor]
- pirlindole [MeSH Supplementary Concept]
- rasagiline [MeSH Supplementary Concept]
- ro 41-1049 [MeSH Supplementary Concept]
- selegiline [MeSH Descriptor]
- toloxatone [MeSH Supplementary Concept]
- tranylcypromine [MeSH Descriptor]
- tribulin [MeSH Supplementary Concept]
Validated automatic mappings to BTNT
- monoamine oxidase a inhibitors [ATC Code]
- monoamine oxidase b inhibitors [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients